These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
22 Apr, 2026, 10.08 PM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
15 Apr, 2026, 09.16 PM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe markets should be in a happy frame of mind till the time the current ceasefire in the Gulf region holds. Not many may like us using the...
08 Apr, 2026, 09.23 PM IST
Alembic Pharma gets USFDA nod to market generic anti-fungal solutionThe company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution (10 per cent).
24 Feb, 2026, 06.31 PM IST
Sudeep Pharma sets IPO price band at Rs 563-593; issue to open on November 21Sudeep Pharma has set a price band of Rs 563–593 for its Rs 895 crore IPO, which opens on November 21. The issue comprises a fresh issue an...
18 Nov, 2025, 03.40 PM IST
Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...
28 Jul, 2025, 06.54 PM IST
Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
28 Jun, 2025, 04.28 PM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 34%Given the way indices and broader markets have panned out, it is very likely that we are going to soon see the market hitting new highs. Th...
10 Jun, 2024, 04.39 PM IST
Alembic Pharma Q4 Results: Posts higher profit on strong N.America salesAlembic Pharma Q4 Results: Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday, driven by stro...
09 May, 2024, 02.53 PM IST
Comeback and re-rating supported by numbers? 5 pharma stocks with upside potential of up to 21%Both at the real business condition and on the valuation cycle on the street. The Indian pharmaceutical sector has undergone significant ch...
04 May, 2024, 04.19 PM IST
After long phase of consolidation: 4 Indian pharma stocks with upside potential of up to 41%Between 2005 to 2015, the pharma sector was one of the best performing sectors with stocks creating big wealth for the shareholders. Then c...
12 Dec, 2023, 12.43 PM IST
Alembic gets USFDA approval to market Clarithromycin tablets in AmericaAlembic's product is therapeutically equivalent to AbbVie Inc's Biaxin Filmtab Tablets, which is antimicrobial indicated to treat mild to m...
01 Feb, 2022, 01.48 PM IST
Bull run in drug stocks face first hurdle as old headache returnsWhile producers of bulk drugs and contract manufacturers have done well for themselves so far, the rally in shares of generic drugs manufac...
13 Aug, 2021, 05.42 PM IST
Market Movers: Why Dr Reddy’s fell & took other drug stocks down with itThe biggest trigger for the nose bleeding fall in Dr Reddy's Labs stock was hidden away in the notes to account of the company’s P&L statem...
27 Jul, 2021, 04.26 PM IST
Alembic Pharma gets USFDA nod for Acyclovir ointmentThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 per cent, Alembi...
09 Apr, 2018, 12.19 PM IST
Alembic Pharma looks to file 100 ANDAs in US in next 3 yearsAn ANDA contains data that provides for the review and ultimate approval of a generic drug product by the United States Food and Drug Admin...
06 Jun, 2017, 05.55 PM IST
Investors fancy pharma in weak market; CNX Pharma hits record highFactors such as weak rupee, new launches and pick-up in exports are bringing investors back in the sector after cyclicals looked stretched.
03 Jul, 2014, 12.44 PM IST